Table 3.
Key outputs and features of the different analysis tools
Method | ||||||
---|---|---|---|---|---|---|
NONMEM | WinNonlin | GraphPad Prism 6.0 | HN-Nonlin | ICEstimator 1.2 | IVART | |
Ease of use | ||||||
Free | ✔ | ✔ | ✔ | |||
96-well formata | ✔ | ✔ | ||||
Batch analysis of multiple drugs | ✔ | ✔ | ✔ | ✔ | ||
Batch analysis of multiple isolates | ✔e | ✔ | ✔ | ✔ | ||
Offline processing | ✔ | ✔ | ✔ | |||
Key output | ||||||
IC50 estimate | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ |
Slope estimate | ✔ | ✔ | ✔ | ✔ | ✔ | |
Confidence interval of estimates | ✔ | ✔ | ✔ | ✔ | ✔ | |
Success criteria and warning signs | ✔ | ✔ | ✔ | ✔ | ||
Dose–response curve | ✔ | ✔ | ✔ | ✔ | ✔ | |
Data processing and analysis | ||||||
Data conversion | Critical | Critical | Easy | Critical | Easy | |
Approximate time needed for data conversion (seconds)b, c | 45 | 25 | 25 | 25 | 25 | |
Data upload/entry | Critical | Critical | Easy | Critical | Easy | |
Approximate time needed for data upload and processing (seconds)b, d | 120 | 15 | 20 | 300 | 90 | |
Approximate total time needed to obtain estimates (seconds) | 165 | 40 | 45 | 325 | 115 |
aBased on the capability to enter the data in 96-well format
bBased on the capability to run one isolate with five different drugs in duplicates distributed on two different 96-well plates
cTime measurement includes the time needed to transfer raw data into a ‘converter’ spreadsheet and double checking the converted data to ensure that raw data was correctly entered and converted
dTime measurement includes the time needed to transfer the converted raw data into the corresponding programs until the outputs were successfully transferred into a separate analysis spreadsheet
eFor NONMEM, data from all isolates are modelled simultaneously